For pediatric patients 1 year to 14 years, what is the nebulized dose of Ipratropium Bromide Inhalation Solution with Albuterol?

Prepare for the ICEMA Medication Standing Orders Test. Hone your knowledge with questions and detailed explanations on various medications and protocols. Excel on your exam!

Multiple Choice

For pediatric patients 1 year to 14 years, what is the nebulized dose of Ipratropium Bromide Inhalation Solution with Albuterol?

Explanation:
Nebulized ipratropium bromide is used in combination with albuterol in a standard single-dose treatment that delivers 0.5 mg of ipratropium per nebulization, paired with 2.5 mg of albuterol. For pediatric patients aged 1 to 14, this 0.5 mg per dose is the commonly used amount because it provides effective bronchodilation while maintaining safety in children. The albuterol component drives rapid relaxation of airway smooth muscle via beta-2 receptors, while ipratropium reduces reflex bronchoconstriction by blocking muscarinic receptors. So the per-dose ipratropium dose in this combination is 0.5 mg. The other listed values don’t match the standard single-dose formulation used for this mix.

Nebulized ipratropium bromide is used in combination with albuterol in a standard single-dose treatment that delivers 0.5 mg of ipratropium per nebulization, paired with 2.5 mg of albuterol. For pediatric patients aged 1 to 14, this 0.5 mg per dose is the commonly used amount because it provides effective bronchodilation while maintaining safety in children. The albuterol component drives rapid relaxation of airway smooth muscle via beta-2 receptors, while ipratropium reduces reflex bronchoconstriction by blocking muscarinic receptors. So the per-dose ipratropium dose in this combination is 0.5 mg. The other listed values don’t match the standard single-dose formulation used for this mix.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy